Patrick MootyVice President, Compliance & Ethics at Sumitomo Dainippon Pharma America
Patrick Mooty leads the team that provides healthcare compliance and transparency reporting services to certain affiliates of Sumitomo Dainippon Pharma Group, including Sunovion Pharmaceuticals and SDP Oncology.
Prior to joining Sunovion in 2016, Patrick was Global Compliance Officer for HeartWare (now Medtronic). Patrick guided the US and international medical and commercial teams, and third party distributors, on the research, development and commercialization of the HVAD ventricular assist device, approved in 56 countries to treat advanced heart failure patients.
Prior to joining HeartWare in 2011, Patrick was Senior Director of Ethics and Compliance at Fresenius Medical Care, the world's largest integrated provider of dialysis products and services. Patrick led compliance efforts for the US medical devices business, and established the compliance program for Fresenius’ new Renal Pharmaceuticals entity.
Prior to joining Fresenius in 2004, Patrick was an attorney specializing in regulatory compliance and taxation matters. He is a graduate of the University of Pennsylvania Carey Law School and Dartmouth College.